{"id":"W2139093684","doi":"10.1158/1078-0432.ccr-08-1159","title":"Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Docetaxel; Metastatic breast cancer; Clusterin; Medicine; Breast cancer; Internal medicine; Regimen; Chemotherapy; Cancer; Oncology; Apoptosis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003129461,0.0001264629,0.0006794751,0.00042337,0.00003870822,0.000008130923,0.0001951814,0.0001129253,0.0006430657],"category_scores_gemma":[0.0009087621,0.0001003815,0.00008877503,0.0009640925,0.0004816725,0.00007729044,0.00009217321,0.0008951483,0.000007347312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002980632,"about_ca_system_score_gemma":0.001116968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001142774,"about_ca_topic_score_gemma":0.001468897,"domain_scores_codex":[0.9967827,0.0006944073,0.0008872118,0.0004437616,0.00073348,0.0004584494],"domain_scores_gemma":[0.9982396,0.0006193509,0.0001295602,0.0004051093,0.0003854804,0.0002208678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5694852,0.04674298,0.09121314,0.0004428323,0.000124043,0.0009681998,0.0007393889,0.00008056267,0.00152814,0.0004051957,0.002433641,0.2858367],"study_design_scores_gemma":[0.4875711,0.02893879,0.4784754,0.001003864,0.0001066613,0.00003328632,0.0001884852,0.001152491,0.0002991571,0.001470075,0.00054509,0.0002156626],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874206,0.0005018503,0.00001061521,0.009780544,0.000156606,0.001472039,0.00006683944,0.00001262668,0.0005783017],"genre_scores_gemma":[0.998126,0.0005848939,0.0001198489,0.0003404338,0.0001894311,0.0003192059,0.0000151657,0.00001717455,0.0002878353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3872622,"threshold_uncertainty_score":0.7041118,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2940175623616857,"score_gpt":0.5994853272054937,"score_spread":0.3054677648438081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}